Insights On Clinical Technologies
-
eSource Purpose Is Not Just To Complete The EDC
7/7/2025
Central eSource transforms data capture from a passive, back-end chore into an active, real-time quality and compliance engine—delivering benefits that extend beyond faster EDC feeds and reduced SDV.
-
GSK And Medable Discuss The Next Phase Of DCTs
3/10/2025
GSK and Medable share the value of embedding DCTs into strategic goals to enhance trial accessibility, diversity, and efficiency.
-
Transforming Clinical Trial Disclosure With AI
10/23/2024
Unlock the full potential of AI to address sponsor challenges including regulatory complexity, clinical trial disclosure requirements, and growing demands for transparency.
-
The Next Steps To Modernize Clinical Trials With DHTs And AI
4/8/2025
Explore an innovative approach to seamless, real-time data capture through wearable sensors that aligns with the FDA's efforts to modernize trials through Digital Health Technologies (DHTs).
-
How Smarter Financial Strategies Improve Trial Performance
3/10/2025
CROs play a critical role in ensuring the financial and operational success of clinical trials, yet outdated budgets and inefficient payment processes continue to create challenges for sites.
-
Introducing TrialKit AI For Advanced Analytics And Reporting
10/4/2024
Check out this workshop introduction to TrialKit AI’s dynamic analytics and reporting capabilities.
-
Simplifying The Data Journey From EHR To EDC
2/29/2024
Explore how open API architecture represents a significant advancement in the integration of EHR and EDC systems, enhancing the potential of EHR data for clinical research.
-
Critical Imaging Risks In GLP-1 And Neurology Studies
5/27/2025
As imaging grows in importance within GLP-1 and neurology trials, it must be treated not as a routine task but as a strategic pillar that supports participant safety and reproducible outcomes.
-
Using eConsent Data To Populate Site And Sponsor Data Systems
10/7/2024
A top-10 pharmaceutical company was looking to reduce the amount of administrative burden on their clinical trial sites and themselves. See how we accomplished it, using eConsent.
-
Evaluating Usability And Incorporating The Patient Experience In DECODE-Nocturnal Scratch
4/22/2024
The DECODE-Nocturnal Scratch group, launched in November 2023, aims to introduce a purpose-built digital measure of nocturnal scratching to enhance patient-focused drug development in dermatology and provide deeper clinical insights.